Patents
Sitemap › C07 - Organic chemistry › C07K - Peptides › C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies
Patents for C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies (149,320)
03/2014
03/05/2014CN103619883A Binding proteins to inhibitors of coagulation factors
03/05/2014CN103619882A T cell receptor-like antibodies specific for a WT1 peptide presented by HLA-A2
03/05/2014CN103619881A Novel EGFR binding proteins
03/05/2014CN103619880A IP-10 antibody dosage escalation regimens
03/05/2014CN103619879A Anti-ngf compositions and use thereof
03/05/2014CN103619878A Serum albumin binding proteins
03/05/2014CN103619877A Modified variable domain molecules and methods for producing and using them b
03/05/2014CN103619876A Bispecific three-chain antibody-like molecules
03/05/2014CN103619875A Engineering of immunoglobulin domains
03/05/2014CN103619874A Soluble integrin [alpha]4 mutant
03/05/2014CN103619871A Compositions relating to a mutant clostridium difficile toxin and methods thereof
03/05/2014CN103619353A Fc receptor binding proteins
03/05/2014CN103614341A Anti-mannan-binding lectin monoclonal antibodies and kit
03/05/2014CN103613675A Herba epimedii polysaccharide and components thereof as well as use of herba epimedii polysaccharide and components thereof as vaccine adjuvants
03/05/2014CN103613667A Enzyme-linked immunosorbent assay technology for glycyrrhizic acid
03/05/2014CN103613666A Preparation method of anti-SARS (severe acute respiratory syndromes) coronavirus surface antibody
03/05/2014CN103613665A Novel egg yolk antibody and preparation method thereof
03/05/2014CN103613664A Avian influenza virus H5N1 antibody molecule, and detection kit and application thereof
03/05/2014CN103613663A Antibody incubation operation method
03/05/2014CN103613563A Preparation method of benzothiostrobin hapten, artificial antigen and specific antibody and application thereof
03/05/2014CN102827275B Method for preparing duck virus hepatitis divalent refined egg yolk antibody
03/05/2014CN102702351B Humanized EV71 antivirus neutralizing antibody EV71FabL6 and preparation method and application thereof
03/05/2014CN102634524B Cell expansion lethal toxin and detection of bacterium belonging to campylobacter genus that targets same
03/05/2014CN101880316B Human RBPMS polypeptide and preparation method of antibody thereof
03/05/2014CN101631802B Anti-human Dlk-1 antibody showing anti-tumor activity in vivo
03/05/2014CN101490086B Deimmunized antagonistic anti-human CD40 monoclonal antibody from ch5D12 antibody
03/04/2014US8664471 Rapidly maturing fluorescent proteins and methods for using the same
03/04/2014US8664368 Fully human monoclonal antibody to VEGF, preparation method and use thereof
03/04/2014US8664366 Fusion proteins forming trimers
03/04/2014US8664364 Optical biosensors
03/04/2014US8664363 Humanized anti-CD22 antibodies and their use in treatment of oncology, transplantation and autoimmune disease
03/04/2014US8664362 Humanized and chimeric anti-properdin antibodies
03/04/2014US8664360 BSL3 polypeptides
03/04/2014US8663943 Antibodies for discrimination of prions
03/04/2014US8663942 Means and methods for the determination of the amount of neurotoxin polypeptide and of its catalytic and proteolytic activities
03/04/2014US8663932 Methods and compositions for wound treatment
03/04/2014US8663652 Regeneration of endogenous myocardial tissue
03/04/2014US8663643 Combinations of an anti-HER2 antibody-drug conjugate and chemotherapeutic agents, and methods of use
03/04/2014US8663641 Anti-PSGL-1 antibodies
03/04/2014US8663640 Methods using recombinant anti-epidermal growth factor receptor antibody compositions
03/04/2014US8663636 Method of treating a malignant tumor by administering antibodies directed to DLL4
03/04/2014US8663634 Methods for the treatment of autoimmune disorders using immunosuppressive monoclonal antibodies with reduced toxicity
03/04/2014US8663598 Anti-human transferrin receptor antibody and uses thereof
03/04/2014CA2533918C Use of adcc-optimized antibodies for treating weak patients
02/2014
02/27/2014WO2014031850A1 A novel polymavirus associated with diarrhea in children
02/27/2014WO2014031822A1 Anti-poly-n-acetyl glucosamine (pnag) monoclonal antibody and uses thereof for the prevention or treatment of pnag expressing bacterial infection
02/27/2014WO2014031718A1 Stable formulations of antibodies to tslp
02/27/2014WO2014031712A1 HUMAN ANTIBODIES TO GFRα3 AND METHODS OF USE THEREOF
02/27/2014WO2014031694A2 Anti-tau antibodies and methods of making and using in treatment of tauopathies
02/27/2014WO2014031668A2 Antibodies to quetiapine and use thereof
02/27/2014WO2014031665A1 Antibodies to quetiapine haptens and use thereof
02/27/2014WO2014031662A2 Antibodies to olanzapine and use thereof
02/27/2014WO2014031648A2 Antibodies to risperidone and use thereof
02/27/2014WO2014031646A2 Molecules with antigen binding and polyvalent fc gamma receptor binding activity
02/27/2014WO2014031645A1 Antibodies to risperidone haptens and use thereof
02/27/2014WO2014031640A2 Antibodies to aripiprazole and use thereof
02/27/2014WO2014031635A1 Antibodies to aripiprazole haptens and use thereof
02/27/2014WO2014031630A2 Antibodies to paliperidone and use thereof
02/27/2014WO2014031610A1 Methods for treating or preventing asthma by administering an il-4r antagonist
02/27/2014WO2014031603A1 Antibodies to paliperidone haptens and use thereof
02/27/2014WO2014031476A1 Mesothelin domain-specific monoclonal antibodies and use thereof
02/27/2014WO2014031174A1 Antibodies and vaccines for use in treating ror1 cancers and inhibiting metastasis
02/27/2014WO2014030780A1 Screening and engineering method of super-stable immunoglobulin variable domains and their uses
02/27/2014WO2014030750A1 MOUSE FcγRII-SPECIFIC Fc ANTIBODY
02/27/2014WO2014030728A1 Fcγriib-specific fc region variant
02/27/2014WO2014030052A2 Compositions comprising an antibody and camostat mesylate (cm)
02/27/2014WO2014029752A1 Anti lrp6 antibodies
02/27/2014WO2014008206A3 DIAGNOSTIC AND THERAPEUTIC POTENTIAL OF HLA-E MONOSPECIFIC MONOCLONAL IgG ANTIBODIES DIRECTED AGAINST TUMOR CELL SURFACE AND SOLUBLE HLA-E
02/27/2014WO2014005014A3 Purification of iduronate-2-sulfatase
02/27/2014WO2014002035A3 A human monoclonal antibody against the vp1 protein of jc virus
02/27/2014WO2013188870A3 IgA CD4i ANTIBODIES AND METHODS OF TREATMENT USING SAME
02/27/2014WO2013165972A3 Anti-hepatitis b virus antibodies and use thereof
02/27/2014WO2013103899A3 Phosphorylation of histones and uses thereof
02/27/2014WO2013012866A8 Methods and compositions for inhibiting polyomavirus-associated pathology
02/27/2014US20140058063 Vitamin receptor binding drug delivery conjugates
02/27/2014US20140057972 Antibody against the csf-1r
02/27/2014US20140057796 Method for the Diagnosis, Prognosis and Treatment of Breast Cancer Metastasis
02/27/2014US20140057319 Methods and Vectors for Generating Asialylated Immunoglobulins
02/27/2014US20140057306 Antibodies to Quetiapine and Use Thereof
02/27/2014US20140057305 Antibodies to Quetiapine Haptens and Use Thereof
02/27/2014US20140057304 Antibodies to Olanzapine and Use Thereof
02/27/2014US20140057303 Antibodies to Olanzapine Haptens and Use Thereof
02/27/2014US20140057302 Antibodies to Risperidone and Use Thereof
02/27/2014US20140057301 Antibodies to Risperidone Haptens and Use Thereof
02/27/2014US20140057300 Antibodies to Aripiprazole and Use Thereof
02/27/2014US20140057299 Antibodies to Aripiprazole Haptens and Use Thereof
02/27/2014US20140057298 Antibodies to Paliperidone and Use Thereof
02/27/2014US20140057297 Antibodies to Paliperidone Haptens and Use Thereof
02/27/2014US20140057294 A hybridoma cell line 10g4 and a monoclonal antibody against the total of aflatoxin b1, b2, g1 and g2
02/27/2014US20140057251 Cannabis Genomes and Uses Thereof
02/27/2014US20140056972 Anti-dclk1 monoclonal antibodies and methods of production and use thereof
02/27/2014US20140056923 Method of treating hypertension disorder and a pharmaceutical agent
02/27/2014US20140056921 Hepatocyte Growth Factor Receptor Antagonists and Uses Thereof
02/27/2014US20140056920 Methods for treating or preventing asthma by administering an il-4r antagonist
02/27/2014US20140056919 Methods and compositions for treating inflammatory conditions
02/27/2014US20140056918 Oscar antagonists
02/27/2014US20140056915 High affinity antibody antagonists of interleukin-13 receptor alpha 1
02/27/2014US20140056914 Human cytomegalovirus neutralising antibodies and use thereof
02/27/2014US20140056913 Anti-dengue virus antibodies and uses thereof
02/27/2014US20140056908 Closterovirus-based nucleic acid molecules and uses thereof
1 ... 60 61 62 63 64 65 66 67 68 69 70 71 72 73 74 75 76 77 78 79 80 ... 1494